163 related articles for article (PubMed ID: 22139406)
1. A bone-seeking clone exhibits different biological properties from the ACHN parental human renal cell carcinoma in vivo and in vitro.
Wang J; Chen A; Yang C; Zeng H; Qi J; Guo FJ
Oncol Rep; 2012 Apr; 27(4):1104-10. PubMed ID: 22139406
[TBL] [Abstract][Full Text] [Related]
2. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases.
Pan T; Fong EL; Martinez M; Harrington DA; Lin SH; Farach-Carson MC; Satcher RL
Cancer Lett; 2015 Aug; 365(1):89-95. PubMed ID: 26004343
[TBL] [Abstract][Full Text] [Related]
4. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.
Pan T; Lin SC; Yu KJ; Yu G; Song JH; Lewis VO; Bird JE; Moon B; Lin PP; Tannir NM; Jonasch E; Wood CG; Gallick GE; Yu-Lee LY; Lin SH; Satcher RL
Neoplasia; 2018 Jan; 20(1):32-43. PubMed ID: 29190493
[TBL] [Abstract][Full Text] [Related]
5. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
[TBL] [Abstract][Full Text] [Related]
6. Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma.
Wang J; You H; Qi J; Yang C; Ren Y; Cheng H
Oncotarget; 2017 Mar; 8(10):17012-17026. PubMed ID: 28199984
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function.
Maita S; Yuasa T; Tsuchiya N; Mitobe Y; Narita S; Horikawa Y; Hatake K; Fukui I; Kimura S; Maekawa T; Habuchi T
Int J Cancer; 2012 Feb; 130(3):677-84. PubMed ID: 21387300
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a new renal cell carcinoma bone metastasis mouse model.
Strube A; Stepina E; Mumberg D; Scholz A; Hauff P; Käkönen SM
Clin Exp Metastasis; 2010 May; 27(5):319-30. PubMed ID: 20443133
[TBL] [Abstract][Full Text] [Related]
9. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic properties of renal cell carcinoma and the pathogenesis of osteolytic bone metastases.
Perut F; Cenni E; Unger RE; Kirkpatrick CJ; Giunti A; Baldini N
Int J Oncol; 2009 May; 34(5):1387-93. PubMed ID: 19360351
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
Kominsky SL; Doucet M; Brady K; Weber KL
J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a new cell line from a renal carcinoma bone metastasis.
Avnet S; Cenni E; Granchi D; Perut F; Amato I; Battistelli L; Brandi ML; Giunti A; Baldini N
Anticancer Res; 2004; 24(3a):1705-11. PubMed ID: 15274344
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of angiogenesis inhibitor TNP-470 on human ACHN renal cell carcinoma.
Zeng J; Mei W; Huang H; Li X; Kong P
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):331-3. PubMed ID: 12674772
[TBL] [Abstract][Full Text] [Related]
14. Eight proteins play critical roles in RCC with bone metastasis via mitochondrial dysfunction.
Wang J; Zhao X; Qi J; Yang C; Cheng H; Ren Y; Huang L
Clin Exp Metastasis; 2015 Aug; 32(6):605-22. PubMed ID: 26115722
[TBL] [Abstract][Full Text] [Related]
15. Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation.
Sakai I; Miyake H; Fujisawa M
BJU Int; 2013 Jul; 112(2):E211-20. PubMed ID: 23305097
[TBL] [Abstract][Full Text] [Related]
16. Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potential.
Miyake H; Gleave ME; Arakawa S; Kamidono S; Hara I
J Urol; 2002 May; 167(5):2203-8. PubMed ID: 11956479
[TBL] [Abstract][Full Text] [Related]
17. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
Weber KL; Pathak S; Multani AS; Price JE
J Urol; 2002 Aug; 168(2):774-9. PubMed ID: 12131367
[TBL] [Abstract][Full Text] [Related]
19. Enhanced sensitivity to sorafenib by inhibition of Akt1 expression in human renal cell carcinoma ACHN cells both in vitro and in vivo.
Tei H; Miyake H; Fujisawa M
Hum Cell; 2015 Jul; 28(3):114-21. PubMed ID: 25862630
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism mediating cytotoxic activity of axitinib in sunitinib-resistant human renal cell carcinoma cells.
Miyazaki A; Miyake H; Fujisawa M
Clin Transl Oncol; 2016 Sep; 18(9):893-900. PubMed ID: 26597115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
